The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
skin tropism, immune recognition of structural/regulatory proteins of varicella-zoster virus, early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients given inactivated varicella vaccine, and the persistence of humoral and cellular immunity in children and adults immunized with live attenuated varicella vaccine. Dr. Arvin's M.D. is from the University of Pennsylvania.
R. Palmer Beasley, M.D., is Dean of the University of Texas-Houston Health Science Center School of Public Health and Professor of Epidemiology. He is the recipient of the 1985 King Faisal International Prize in Medicine and the 1987 Charles F. Mott General Motors International Prize for Research on Cancer. Among Dr. Beasley's research accomplishments are studies leading to the understanding of the routes, mechanisms, and timing of the transmission of Hepatitis B Virus (HBV). He helped develop the World Health Organization policy guidelines on HBV immunization and the global HBV control program, and is currently a WHO consultant on HIV and HBV. Dr. Beasley's M.D. is from Harvard University.
Kenneth I. Berns, M.D., Ph.D., is Interim Vice-President for Health Affairs and Dean of the College of Medicine at the University of Florida. He has served as a member of the Composite Committee of the United States Medical Licensing Examination, Chairman of the Association of American Medical Colleges, President of the Association of Medical School Microbiology and Immunology Chairs, President of the American Society for Virology, President of the American Society for Microbiology and Vice-President of the International Union of Microbiological Societies. He is a member of the National Academy of Sciences and the Institute of Medicine. Dr. Berns' research examines the molecular basis of replication of the human parvovirus, adenoassociated virus, and the ability of an adeno-associated virus to establish latent infections and be reactivated. His work has helped provide the basis for use of this virus as a vector for gene therapy. Dr. Berns' M.D. and his Ph.D. in Biochemistry are from The Johns Hopkins University.
Raphael Dolin, M.D., is Dean of the Office for Clinical Programs at Harvard Medical School. He is a past member of the Board of Scientific Counselors of NIAID, the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration, and the Sub-Specialty Board in Infectious Diseases of the American Board of Internal Medicine. He is past Chair of the Executive Committee of the NIAID AIDS Vaccine Evaluation Group and is currently a member of the NIAID AIDS Research Advisory Committee and the National Institutes of Health AIDS Vaccine Research Committee. His research interests include laboratory and clinical investigation of viral pathogerlesis, antiviral chemotherapy, and viral vaccines. Recent publications address analysis